May 16, 2025

Delandistrogene Moxeparvovec: Efficacy Evidence Questioned

The AAN Guidelines Subcommittee review finds delandistrogene moxeparvovec for DMD failed to meet primary functional outcomes despite FDA approval.

Conexiant

May 15, 2025

Assistant Professor Salary Gaps Persist Nationwide

Persistent salary disparities by gender, race, and ethnicity were identified among more than 45,000 U.S. assistant professors, with underrepresented in medicine women learning the least across all specialties.

Conexiant

May 15, 2025

Medical Oddities: Mini Lab-Grown Ovaries Go Natural

Mini ovaries steal the show—plus heart cell choreography, Brussels sprout bias, and prenatal tea perks.

Conexiant

May 14, 2025

Oral Option Now Available for PPGL

The FDA approved belzutifan as the first oral therapy for advanced pheochromocytoma and paraganglioma in patients aged 12 years and older.

Conexiant

May 14, 2025

Prenatal Testosterone: Shaping Children's Fitness?

New study finds maternal testosterone exposure during pregnancy affects physical activity in boys and muscle strength in girls at age 7, with potential implications for long-term cardiovascular health.

Conexiant

May 13, 2025

Ingestible Fluoride Rx for Kids Pulled

"Ending the use of ingestible fluoride is long overdue," Health Secretary Robert F. Kennedy Jr. said.

Reuters

May 12, 2025

Delayed Puberty: Diabetes Risk Signal?

"Our results are surprising as delayed puberty is generally considered a benign condition."

Conexiant

May 12, 2025

Prenatal Cannabis Use Tied to Adverse Birth Outcomes

Researchers report that prenatal cannabis use is associated with increased risks of low birth weight, preterm birth, and small for gestational age.

Conexiant

May 08, 2025

FDA Warns Physicians of Tianeptine Dangers

The FDA warns physicians about unapproved tianeptine products that are linked to severe adverse events, including dependence, toxicity, and death.

Conexiant